Faeth Therapeutics Inc. (FTH) Live Share Price, Invest From India

Faeth Therapeutics Inc. Stock Performance

as on August 1, 2026 at 2:16 pm IST

Day's Low
Day's High
$26.26
Day's Price Range
$29.70
$27.24
3.60%
Downside
9.03%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$27.24
100.00%
Downside
-100.00%
Upside

Faeth Therapeutics Inc. share price movements today

Previous Close: $28.82
Open: $28.76
Volume: 233.5K
Day's Low - High: $26.26 - $29.70

Faeth Therapeutics Inc. Historical Returns

1 Month Return: + 18.85 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Faeth Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Faeth Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$742.9M

EPS (TTM)

-73.414

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Faeth Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Faeth Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Faeth Therapeutics Inc.	NA	$742.9M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.9B	539.16%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	140.57%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.14%	16.98	29.65%	NA

Indian Investors' Interest in Faeth Therapeutics Inc. Stock

Search interest for Faeth Therapeutics Inc. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 3, 2026 to August 2, 2026

Change:-23% versus previous 30 day period

Faeth Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-4	-	-
Gross Profit	-	-	-	-	-132
Operating Income	-7	-5	-4	-4	-170
EBITDA	-6	-4	-4	-4	-170
Interest Expense	0	0	0	0	-
Depreciation	0	0	0	0	0
Income Before Tax	-6	-4	-4	-4	-170
Income Tax Expense	-	-	-	-	-
Net Income	-6	-4	-4	-4	-170
Net Profit Margin	0.00%	0.00%	94.19%	0.00%	0.00%

Faeth Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	-1	0	0	-
Operating Income	-49	-37	-31	-22
EBITDA	-46	-33	-29	-20
Interest Expense	0	0	0	0
Depreciation	1	1	1	0
Income Before Tax	-48	-34	-30	-21
Income Tax Expense	-	-	-	-
Net Income	-48	-34	-30	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Faeth Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-7	-7	-7	-6	-4	-4	-4	-170
Operating Cash Flow	-7	-5	-5	-5	-7	-5	-3	-3	-10
Investing Cash Flow	5	6	12	-3	7	8	1	2	-31
Financing Cash Flow	0	0	0	0	0	0	0	0	185
Change in Cash	-2	0	7	-9	0	2	-1	-1	143

Faeth Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-20	-36	-48	-34	-30	-21
Operating Cash Flow	-8	-17	-30	-39	-32	-24	-20
Investing Cash Flow	0	-1	-143	49	38	22	19
Financing Cash Flow	8	35	163	0	-11	0	0
Change in Cash	0	16	-9	10	-4	-3	-1

Global Institutional Holdings in Faeth Therapeutics Inc.

Funds	Holdings
HRT FINANCIAL LLC	0.23%
Bank of America Corp	0.13%
Franklin Resources Inc	0.52%
Caligan Partners LP	0.49%
Trails Edge Capital Partners, LP	0.48%

See all

Insights on Faeth Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, FTH stock has moved up by 197.4%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 472.1% return, outperforming this stock by 463.1%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 248.2%

About Faeth Therapeutics Inc.

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.

Organisation	Faeth Therapeutics Inc.
Headquarters	1405 Research Boulevard, Rockville, MD, United States, 20850
Industry	Biotechnology
CEO	Mr. Josiah Craver CPA
E-voting on shares	Click here to vote

Key Management of Faeth Therapeutics Inc.

Name	Title
Mr. Josiah Craver CPA	Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer
Mr. Christopher W. Gerry J.D.	General Counsel & Secretary

FAQs

What is Faeth Therapeutics Inc. share price today?

Faeth Therapeutics Inc. share price today is $27.24 as on August 1, 2026 at 8:46 am IST at the close of the market. Faeth Therapeutics Inc. share today touched a day high of $29.70 and a low of $26.26.

What is the 52 week high and 52 week low for Faeth Therapeutics Inc. share?

Faeth Therapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Faeth Therapeutics Inc. stock price today i.e. August 1, 2026 at 8:46 am IST is closed at $27.24,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Faeth Therapeutics Inc.'s market capitalisation today?

Faeth Therapeutics Inc. market capitalisation is $0.00T as on August 1, 2026 at 8:46 am IST.

How to invest in Faeth Therapeutics Inc. Stock (FTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Faeth Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Faeth Therapeutics Inc. Shares that will get you 0.0551 shares as per Faeth Therapeutics Inc. share price of $27.24 per share as on August 1, 2026 at 8:46 am IST.

What is the minimum amount required to buy Faeth Therapeutics Inc. Stock (FTH) from India?

Indian investors can start investing in Faeth Therapeutics Inc. (FTH) shares with as little as ₹95.39 or $1 (as of August 2, 2026 at 2:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in Faeth Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 2, 2026 at 2:39 pm IST). Based on Faeth Therapeutics Inc. share’s latest price of $27.24 as on August 1, 2026 at 8:46 am IST, you will get 0.3671 shares of Faeth Therapeutics Inc.. Learn more about fractional shares .